Vetoquinol - Universal Registration Document - 2021

1 4 Vetoquinol Universal Registration Document 2020 Financial report PRESENTATION OF THE GROUP 2020, an unprecedented year of mobilization This past year has been significant in many ways and there are several lessons to be learned from it that I would like to highlight. The resilience of the animal health market: our market grew by more than 4% in 2020, demonstrating the solid fundamentals of both our food-producing animals and pet segments, despite the unprecedented global health crisis. Throughout the year, Vetoquinol has demonstrated the strength of its collective performance: we made the right decisions to preserve the health and safety of our teams and to ensure the continuity of our operations. We have shown flexibility in adapting, responding to our customers’ needs and gaining market share in the process. Vetoquinol completed a major transforming operation with the purchase of the Drontal ® and Profender ® product families in Europe and the UK. This acquisition has confirmed our hybrid growth model, which is based on the fulfillment of our organic growth ambitions supported by the contribution of external growth activities. I am proud of the commitment of our teams, our collective strength and the results we have achieved in 2020. The COVID-19 health crisis is not over, and we remain mobilized to address it. The experience we have gained from managing this crisis has enabled us to demonstrate our flexibility and our constant efforts to combine respect for the values we hold dear, the safety of our teams and the resilience of our business model, which is the guarantee of our laboratory’s independence and durability. Matthieu Frechin Chief Executive Officer 1.1 2020, an unprecedented year of mobilization